A new malaria vaccine, developed by the University of Oxford, is recommended by WHO. Women face inequalities in cancer care. Nobel Prize awarded for mRNA vaccine development. The efficacy of mental health first aid courses is debated.
The World Health Organization has recommended the use of a cheap vaccine, R21, as a breakthrough in the fight against malaria, with an effectiveness rate of 75%.
The Lancet Commission on Women, Power, and Cancer highlights the importance of a feminist approach to cancer care, addressing inequalities and improving outcomes for women with cancer.
Deep dives
Malaria Vaccine: A Breakthrough in the Fight Against Malaria
The World Health Organization has recommended the use of a cheap vaccine, R21, as a breakthrough in the fight against malaria. Malaria is caused by a complex parasite, and developing an effective vaccine has been challenging. The R21 vaccine has shown promising results in trials and has now been approved, with an effectiveness rate of 75%. It works by artificially tagging the parasite onto a protein made by the hepatitis B virus, effectively alerting the immune system. This vaccine has the potential to prevent a significant number of malaria cases, particularly in areas where it is widespread.
A Feminist Approach to Cancer Care: Addressing Inequalities and Challenges
The Lancet Commission on Women, Power, and Cancer highlights the importance of a feminist approach to cancer care. The commission's report identifies various factors that affect women's health, including exposure to cancer risk factors and a lack of access to accurate information. It also highlights that women are not always taken seriously when presenting symptoms, leading to delays in diagnosis and treatment. Addressing these inequalities requires a multilevel approach, considering the intersectionality of gender, age, race, ethnicity, and income. By empowering women, promoting equity, and improving healthcare systems, it is possible to achieve better outcomes for women with cancer.
Nobel Prize for mRNA Vaccine Pioneers Drew Weisman and Kathleen Carrico
Professors Drew Weisman and Kathleen Carrico have been awarded the Nobel Prize in Physiology or Medicine for their pioneering work on mRNA vaccines, which led to the development of highly effective COVID-19 vaccines. Their breakthrough involved modifying artificial mRNA to mimic naturally produced mRNA, allowing it to evade the immune response and stimulate the production of specific proteins. This revolutionary approach enabled the rapid development of mRNA vaccines and resulted in unprecedented levels of efficacy, such as the 95% effectiveness of COVID-19 mRNA vaccines. Their work represents a major milestone in vaccine development and has saved millions of lives worldwide.
A vaccine for malaria that can be produced cheaply on a large scale has been recommended for use by the World Health Organisation. It was developed by the University of Oxford, and is only the second malaria vaccine to be developed.
Claudia Hammond is joined by New Scientist health reporter Clare Wilson to look at how the new vaccine works, and why it’s proven so hard to find a way to inoculate against malaria.
We also look at major new research that’s found women are facing major inequalities in cancer care around the world, with calls for a feminist approach to cancer prevention, detection, and treatment.
Claudia and Clare also discuss this week’s announcement of the Nobel Prize in Physiology or Medicine. Professors Katalin Karikó and Drew Weissman are sharing the prize for their work developing the technology that led to the mRNA Covid vaccines.
And we hear whether or not there’s evidence that mental health ‘first aid’ courses have real medical benefits.
Presenter: Claudia Hammond
Producer: Dan Welsh
Editor: Erika Wright
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode